Page last updated: 2024-08-16

vesnarinone and piperidines

vesnarinone has been researched along with piperidines in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayashida, W; Kawai, C; Kumada, T	1
Matsumori, A; Nose, Y; Ono, K; Sasayama, S; Sato, Y; Shioi, T	1
Cheng, J; Kamiya, K; Kodama, I; Lee, JK; Suzuki, R; Toyama, J	1

Reviews

1 review(s) available for vesnarinone and piperidines

Article	Year
[New oral drugs for the treatment of congestive heart failure]. Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:2 Topics: Administration, Oral; Cardiotonic Agents; Deoxyepinephrine; Ethanolamines; Heart Failure; Humans; Phosphodiesterase Inhibitors; Piperidines; Propanolamines; Pyrazines; Quinolines; Quinolones; Vasodilator Agents; Xamoterol	1992

Other Studies

2 other study(ies) available for vesnarinone and piperidines

Article	Year
Differential modulation of cytokine production by drugs: implications for therapy in heart failure. Journal of molecular and cellular cardiology, 1996, Volume: 28, Issue:12 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Heart Failure; Humans; Interleukin-1; Interleukin-6; Kinetics; Leukocytes, Mononuclear; Lipopolysaccharides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pyrazines; Pyridazines; Quinazolines; Quinolines; Tumor Necrosis Factor-alpha	1996
Vesnarinone prolongs action potential duration without reverse frequency dependence in rabbit ventricular muscle by blocking the delayed rectifier K+ current. Circulation, 1997, Nov-18, Volume: 96, Issue:10 Topics: Action Potentials; Adjuvants, Immunologic; Animals; Anti-Arrhythmia Agents; Delayed Rectifier Potassium Channels; Electric Conductivity; Male; Myocardium; Papillary Muscles; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyrazines; Pyridines; Quinolines; Rabbits; Reaction Time; Ventricular Function	1997

Article

Year

Differential modulation of cytokine production by drugs: implications for therapy in heart failure.

Journal of molecular and cellular cardiology, 1996, Volume: 28, Issue:12

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Heart Failure; Humans; Interleukin-1; Interleukin-6; Kinetics; Leukocytes, Mononuclear; Lipopolysaccharides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pyrazines; Pyridazines; Quinazolines; Quinolines; Tumor Necrosis Factor-alpha

1996

Vesnarinone prolongs action potential duration without reverse frequency dependence in rabbit ventricular muscle by blocking the delayed rectifier K+ current.

Circulation, 1997, Nov-18, Volume: 96, Issue:10

Topics: Action Potentials; Adjuvants, Immunologic; Animals; Anti-Arrhythmia Agents; Delayed Rectifier Potassium Channels; Electric Conductivity; Male; Myocardium; Papillary Muscles; Piperidines; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Pyrazines; Pyridines; Quinolines; Rabbits; Reaction Time; Ventricular Function

1997